Prof. Tony Shu-Kam Mok
Professor · Chairman of Clinical Oncology
Academic Profile
Academician Tony Mok (Shu-Kam Mok) is Chairman of the Department of Clinical Oncology at CUHK Faculty of Medicine and an international authority in lung cancer research — a foreign member of the Chinese Academy of Sciences. Landmark trials he led, including IPASS, established the global targeted-therapy paradigm for EGFR-mutant lung cancer and repeatedly rewrote international guidelines.
A key figure bridging Chinese and international oncology research, he has led numerous international multicenter trials that advanced the globalization of precision lung cancer care.
Appointments & Honors
- Chairman of Clinical Oncology at CUHK; Director of the Sir YK Pao Centre for Cancer at Prince of Wales Hospital
- First author of the IPASS study, which established first-line targeted therapy for EGFR-mutant lung cancer
- Recipient of the ESMO Lifetime Achievement Award; expert in multiple international guidelines
Appointments
- Chairman, Dept. of Clinical Oncology, CUHK
- Foreign Member, Chinese Academy of Sciences
- Past President, IASLC
Areas of Expertise
- Targeted therapy and precision care for lung cancer
- International multicenter clinical trials
- Lung cancer biomarker research
Academic Achievements
- IPASS established the targeted-therapy paradigm for EGFR-mutant lung cancer
- Foreign Member of CAS
- Repeatedly led landmark trials rewriting international lung cancer guidelines
Selected Publications
Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma (IPASS)
New England Journal of Medicine · 2009
First author
Osimertinib or platinum–pemetrexed in EGFR T790M-positive lung cancer (AURA3)
New England Journal of Medicine · 2017
First author
Cancer Focus
Targeted Therapy & Immunotherapy for Lung Cancer
Outpatient Schedule
| Wed PM · Oncology Consultation (Hong Kong) |
| Fri AM · Lung Cancer MDT |
Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.
Available Hospitals
CASE FEASIBILITY REVIEW
Submit Your Case for a Free Review
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
- No medical file upload required at this stage
- By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.